Skip to content

DOKTERS LAMMAR – VERELST

Active Private limited companyfounded 2017active for 8 yearsHoogland 8, 2800 MechelenKBO/BCE: BE 0686.748.914

Lifetime

8 annual accounts with figures on one time axis
peak of €318,073 in 2025
€318,073▲ 1.4%
peak of €201,148 in 2024
€199,149▼ 1.0%
peak of €871,911 in 2025
€871,911▲ 11.6%
€12,859▼ 77.5%
Board2 names since 2017
2 directors and 1 other
Documentsfilings and deeds
07-07-202624 days before the deadline
2025micro format
Dividend €108,412Debts from €57,269 to €12,859

Key points

from the 2025 annual accounts

Equity

€871,911 ▲ 11.6%

DOKTERS LAMMAR – VERELST has made a profit in every financial year since 2018.

Turnover

≈ €490,000 estimated

The micro format states no turnover.

Investments

€56,193 1.6 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Liquidity

69.57 was 15.37 in 2024

Short-term debts fell from €49,556 to €11,301.

Filings

8 annual accounts 1 late
AprilJune31 JulyOctober20202025

The 2019 accounts came 33 days late. The other seven were filed on time.

Position in the sector

98.5%

Higher solvency than 95% of companies in human health. The sector median is 63.1%, over 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,785 companies had the same profile as DOKTERS LAMMAR – VERELST has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,785 companies, not a prediction for DOKTERS LAMMAR – VERELST. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 93 sharesdeed of 28-12-2017
  • 93 sharesdeed of 28-12-2017
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0686748914
(statutory director) and (statutory director) change roles Discharge granted to (statutory manager) · Discharge granted to (statutory manager) · General meeting of 11-12-2023 · Gazette deed
Registered office moved within Mechelen The registered office moved from Zwartzustersvest 23 bus 405- 2800 Mechelen to HOOGLAND 8 TE 2800 MECHELEN · Board meeting of 17-10-2020 · Gazette deed
Incorporation Founding capital of €18,600, 186 shares, €6,200 paid up · Founded by and · (statutory manager) and (statutory manager) appointed · published on 28-12-2017 · Gazette deed
All 21 events

Comparable companies

same main activity, similar in size and age
Company
DOKTERS LAMMAR – VERELST Mechelen €884,771 €318,073 98.5% -
DR. Ingeborg JACOBS Ranst €831,064 €309,993 94.2% -
DOKTER LORE VAN CASTEREN Hulshout €857,768 €280,182 30.4% -
DOKTER KAREN SINNESAEL Veurne €891,275 €310,502 40.1% -
HUISARTSENPRAKTIJK, Dr. INGE DE GUSSEM Kaprijke €855,350 €303,186 60.1% -
SOCIETE DE MEDECINE WOESTYN CAROLINE Comines-Warneton €765,595 €328,008 92.8% 1.9
Huisartsenpraktijk Ten Aard Geel €974,504 €288,426 27.6% -

These companies have the same main activity as DOKTERS LAMMAR – VERELST: general medical practice (NACE 86210). They are comparable in size and age: total assets between €766,000 and €975,000, founded between 2017 and 2019.

Official details

Source: KBO
Status
Active since 22-12-2017Normal situation
Activity
General medical practiceNACE 86210
Establishment units
2.271.205.8072800 Mechelen, since 22-12-2017
2.271.206.9931982 Zemst, since 22-12-2017
Financial year end
31 December
Peppol
Reachable since 23-12-2025
Company details

Annual accounts 2025

€884,771▲ 5.5%
Filing
Filed on 07-07-2026, 24 days before the end of the filing period
Financials

Insights on DOKTERS LAMMAR – VERELST

DOKTERS LAMMAR – VERELST files the micro format. That format states no turnover. The gross margin rose from €63,181 in 2018 to €318,073 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOKTERS LAMMAR – VERELST

What is the company number of DOKTERS LAMMAR – VERELST?
The company number of DOKTERS LAMMAR – VERELST is 0686.748.914. The VAT number is the same number with BE in front: BE 0686.748.914.
Where is DOKTERS LAMMAR – VERELST based?
The registered office is at Hoogland 8, 2800 Mechelen.Company details
What does DOKTERS LAMMAR – VERELST do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOKTERS LAMMAR – VERELST?
DOKTERS LAMMAR – VERELST is a private limited company (BV).
When was DOKTERS LAMMAR – VERELST founded?
DOKTERS LAMMAR – VERELST was founded on 22-12-2017.
Is DOKTERS LAMMAR – VERELST still active?
Yes, DOKTERS LAMMAR – VERELST is an active enterprise in the KBO register.
What is the turnover of DOKTERS LAMMAR – VERELST?
The turnover in financial year 2025 is about €490,000. This figure is estimated from the gross margin of €318,073 and 38 comparable companies (NACE 862). It probably lies between €420,000 and €610,000.Financials
Is DOKTERS LAMMAR – VERELST profitable?
In financial year 2025, DOKTERS LAMMAR – VERELST made a profit of €199,149.
Where can I find the annual accounts of DOKTERS LAMMAR – VERELST?
DOKTERS LAMMAR – VERELST filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTERS LAMMAR – VERELST due?
DOKTERS LAMMAR – VERELST must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.